Journal of Clinical Endocrinology & Metabolism, Vol 79, 1818-1823, Copyright © 1994 by Endocrine Society

ARTICLES

A sporadic case of male-limited precocious puberty has the same constitutively activating point mutation in luteinizing hormone/choriogonadotropin receptor gene as familial cases

K Yano, A Hidaka, M Saji, MH Polymeropoulos, A Okuno, LD Kohn and GB Cutler Jr
Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892.

Familial male-limited precocious puberty (FMPP) is an autosomal dominant disorder characterized by marked elevation of serum testosterone despite low levels of gonadotropin. Recently, a single point mutation in the LH/hCG receptor (LH/CGR) gene was found in FMPP families that constitutively activates the LH/CGR, causing Leydig cell activation and precocious puberty. Among the Japanese population, only four sporadic cases of male-limited precocious puberty have been reported. In the current study, we examined one of the four reported Japanese patients with sporadic male-limited precocious puberty and found the same mutation as that in the FMPP families. Genomic DNA was isolated, and the polymerase chain reaction (PCR) was performed to amplify a fragment of LH/CGR DNA encoding amino acid residues that include transmembrane helixes 5 and 6. Sequencing of the PCR products revealed a heterozygous adenosine-guanine transition at nucleotide 1733 in codon 578. The mutation encodes an aspartic acid578-glycine substitution in transmembrane helix 6. The mutant LH/CGR, created by site-directed mutagenesis in vitro, exhibited constitutively higher cAMP levels in transfected COS-7 cells than the wild-type LH/CGR, as described previously; however, basal inositol phosphate levels were not increased by transfection with complementary DNA for the mutant receptor. The concentration and affinity of [125I]hCG-binding sites were similar in cells transfected with the mutant and wild-type LH/CGR complementary DNAs, indicating that the mutant did not alter the production of receptor or its ability to bind human LH/CG. The sporadic occurrence of this case was confirmed by further studies. The mutation creates a recognition site for the restriction endonuclease MspI. Restriction digestion was positive for the mutant not digested by MspI, indicating that the patient's mutant allele was not inherited from his parents. DNA analysis of the patient and the parents, using microsatellite repeat markers, was compatible with biological paternity and maternity. We conclude that the aspartic acid578-->glycine mutation in the LH/CGR has arisen in the Japanese population and is the cause of a sporadic case of male-limited precocious puberty.

This article has been cited by other articles:

				K. Angelova, F. Fanelli, and D. Puett Contributions of Intracellular Loops 2 and 3 of the Lutropin Receptor in Gs Coupling Mol. Endocrinol., January 1, 2008; 22(1): 126 - 138. [Abstract] [Full Text] [PDF]

				G. L. Ryan, X. Feng, C. B. d'Alva, M. Zhang, B. J. Van Voorhis, E. M. Pinto, A. E. F. Kubias, S. R. Antonini, A. C. Latronico, and D. L. Segaloff Evaluating the Roles of Follicle-Stimulating Hormone Receptor Polymorphisms in Gonadal Hyperstimulation Associated with Severe Juvenile Primary Hypothyroidism J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2312 - 2317. [Abstract] [Full Text] [PDF]

				A. C. Latronico, H. Shinozaki, G. Guerra Jr., M. A. A. Pereira, S. H. V. Lemos Marini, M. T. M. Baptista, I. J. P. Arnhold, F. Fanelli, B. B. Mendonca, and D. L. Segaloff Gonadotropin-Independent Precocious Puberty Due to Luteinizing Hormone Receptor Mutations in Brazilian Boys: A Novel Constitutively Activating Mutation in the First Transmembrane Helix J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4799 - 4805. [Abstract] [Full Text]

				A. P. N. Themmen and I. T. Huhtaniemi Mutations of Gonadotropins and Gonadotropin Receptors: Elucidating the Physiology and Pathophysiology of Pituitary-Gonadal Function Endocr. Rev., October 1, 2000; 21(5): 551 - 583. [Abstract] [Full Text]

				H. Kremer, J. W. M. Martens, M. van Reen, M. Verhoef-Post, J. M. Wit, B. J. Otten, S. L. S. Drop, H. A. Delemarre-van de Waal, M. Pombo-Arias, F. De Luca, et al. A Limited Repertoire of Mutations of the Luteinizing Hormone (LH) Receptor Gene in Familial and Sporadic Patients with Male LH-Independent Precocious Puberty J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 1136 - 1140. [Abstract] [Full Text]

				A. N. Abell, D. J. McCormick, and D. L. Segaloff Certain Activating Mutations within Helix 6 of the Human Luteinizing Hormone Receptor May Be Explained by Alterations That Allow Transmembrane Regions to Activate Gs Mol. Endocrinol., December 1, 1998; 12(12): 1857 - 1869. [Abstract] [Full Text]

				J. Gromoll, C.-J. Partsch, M. Simoni, V. Nordhoff, W. G. Sippell, E. Nieschlag, and B. B. Saxena A Mutation in the First Transmembrane Domain of the Lutropin Receptor Causes Male Precocious Puberty J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 476 - 480. [Abstract] [Full Text]

				K. Yano, L. D. Kohn, M. Saji, A. Okuno, and G. B. Cutler Jr. Phe576 Plays an Important Role in the Secondary Structure and Intracellular Signaling of the Human Luteinizing Hormone/Chorionic Gonadotropin Receptor J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2586 - 2591. [Abstract] [Full Text] [PDF]

				S. Kosugi, T. Mori, and A. Shenker The Role of Asp578 in Maintaining the Inactive Conformation of the Human Lutropin/Choriogonadotropin Receptor J. Biol. Chem., December 13, 1996; 271(50): 31813 - 31817. [Abstract] [Full Text] [PDF]

				M. Kudo, Y. Osuga, B. K. Kobilka, and A. J.W. Hsueh Transmembrane Regions V and VI of the Human Luteinizing Hormone Receptor Are Required for Constitutive Activation by a Mutation in the Third Intracellular Loop J. Biol. Chem., September 13, 1996; 271(37): 22470 - 22478. [Abstract] [Full Text] [PDF]

				P. A. Clark and W. L. Clarke Testotoxicosis: An Unusual Presentation and Novel Gene Mutation Clinical Pediatrics, May 1, 1995; 34(5): 271 - 274. [PDF]